Literature DB >> 16002739

Genetic dissection of systemic lupus erythematosus pathogenesis: partial functional complementation between Sle1 and Sle3/5 demonstrates requirement for intracellular coexpression for full phenotypic expression of lupus.

Masatoshi Wakui1, Laurence Morel, Edward J Butfiloski, Chunsun Kim, Eric S Sobel.   

Abstract

Sle1 on chromosome 1 and Sle3/5 on chromosome 7 are two of the most critical lupus susceptibility loci of the New Zealand Black/White-derived NZM2410 mouse strain. In contrast to C57BL/6 mice congenic for either Sle1 (B6.Sle1) or Sle3/5 (B6.Sle3/5), strains that express only a modest lupus-related phenotype, the bicongenic B6.Sle1.Sle3/5 strain has a robust phenotype, suggesting a critical role for epistatic interactions in lupus pathogenesis. Mixed chimera experiments indicated that the two loci are functionally expressed by different cell populations and predicted that phenotypic expression of the phenotypic features of the B6.Sle1.Sle3/5 strain could be fully reproduced with a combination of B6.Sle1 and B6.Sle3/5 bone marrow. Contrary to our expectations, there was only a partial functional complementation in these mixed chimeras. Spleen enlargement, CD4:CD8 ratio elevation, and epitope spreading of autoantibodies were fully developed in B6+B6.Sle1.Sle3/5 but not in B6.Sle1+B6.Sle3/5 mixed chimeras. This study is the first to present evidence that the pathways mediated by two critical lupus susceptibility loci derived from the New Zealand White strain must be integrated intracellularly for epistatic interactions to occur. Our mixed chimera approach continues to provide novel insights into the functional genetic pathways underlying this important murine model of systemic autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002739     DOI: 10.4049/jimmunol.175.2.1337

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Infection in systemic lupus erythematosus: friend or foe?

Authors:  Lisa Francis; Andras Perl
Journal:  Int J Clin Rheumtol       Date:  2010-02-01

2.  Latent membrane protein 1, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Sle1 mice.

Authors:  Anna L Peters; Laura L Stunz; David K Meyerholz; Chandra Mohan; Gail A Bishop
Journal:  J Immunol       Date:  2010-09-01       Impact factor: 5.422

3.  Anti-nuclear antibody production and autoimmunity in transgenic mice that overexpress the transcription factor Bright.

Authors:  Malini Shankar; Jamee C Nixon; Shannon Maier; Jennifer Workman; A Darise Farris; Carol F Webb
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

Review 4.  Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models.

Authors:  Subhrajit Saha; Arlene Tieng; K Peter Pepeljugoski; Gisele Zandamn-Goddard; Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

5.  Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms.

Authors:  Takashi Miwa; Michael A Maldonado; Lin Zhou; Koei Yamada; Gary S Gilkeson; Robert A Eisenberg; Wen-Chao Song
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

6.  Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus.

Authors:  Tianfu Wu; Xiangmei Qin; Zoran Kurepa; Kirthi Raman Kumar; Kui Liu; Hasna Kanta; Xin J Zhou; Anne B Satterthwaite; Laurie S Davis; Chandra Mohan
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.